Found: 5
Select item for more details and to access through your institution.
Three‐year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. e86, doi. 10.1111/bjh.16499
- By:
- Publication type:
- Article
Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 3, p. 1, doi. 10.1093/jncics/pkab027
- By:
- Publication type:
- Article
Complete Response to Dual Immunotherapy in a Young Adult with Metastatic Alveolar Soft Part Sarcoma Enabled by a Drug Recovery Program in a Community Practice.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2020, v. 9, n. 3, p. 449, doi. 10.1089/jayao.2019.0113
- By:
- Publication type:
- Article
Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 4, p. 883, doi. 10.1002/pbc.21161
- By:
- Publication type:
- Article
Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics.
- Published in:
- Oncologist, 2022, v. 27, n. 5, p. 363, doi. 10.1093/oncolo/oyac030
- By:
- Publication type:
- Article